Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Sage Therapeutics Inc
Today
Create an eToro account to buy SAGE stock on a secure, user-friendly, multi-asset trading platform.
Buy Sage Therapeutics Inc
SAGE Price
Sage Therapeutics Inc SAGE
Buy SAGE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
SAGE Price

Sage Therapeutics Inc SAGE

$5.480.04(0.74%)(1D)

SAGE Stock Price Chart

4.97%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Sage Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Sage Therapeutics Inc share price today is 5.48, reflecting a 0.74% change over the last 24 hours and 1.67% over the past week. The current market capitalization of SAGE is 335.23M with an average volume in the last three months of 937994.75. The stock has a P/E ratio of -0.98 and a dividend yield of 0%. With the stock’s beta sitting at 1.24
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$335.23M
Day’s Range
i
Shows the high and low prices of the day.
4.91 - 5.89
52W Range
i
Shows the high and low prices of the last year.
4.69 - 59.84
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
937994.75
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-0.98
Revenue
i
The total income generated by this company’s goods and services last year.
$106.4M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$5.48
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-5.58
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.24
What Is Sage Therapeutics Inc?
Sage Therapeutics Inc is an American clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapies aimed at treating people with debilitating brain and central nervous system (CNS) disorders. The company is developing treatments for a range of depressive, neurological, and neuropsychiatric disorders. Operating globally, the firm was founded in 2010 and is based in Cambridge, Massachusetts.

The focus of the firm’s research and development is on modulation of two critical neurotransmitter systems: GABA and NMDA receptors. These systems are the major signalling pathways of the brain and central nervous system, and it is understood that both contribute significantly to regulating CNS function. Eliminating dysfunction in these two systems is potentially the key to effectively treating numerous conditions, including depressive disorders.

The firm’s product Zulresso is a prescription medication for the treatment of new mothers suffering from post-partum depression. Other treatments in the Sage Therapeutics pipeline are aimed at addressing treatment-resistant depression, generalised anxiety disorder, bipolar disorder, Alzheimer’s disease, and the cognitive dysfunction associated with Parkinson’s disease. The firm publicly trades on the NASDAQ, where it is listed under the stock ticker SAGE.

Start monitoring Sage Therapeutics Inc value changes by adding SAGE stock to your eToro watchlist.
Buy SAGE

How can I buy Sage Therapeutics Inc stocks?

To purchase Sage Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Sage Therapeutics Inc (SAGE) page and place an order to buy Sage Therapeutics Inc.
Buy SAGE
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Sage Therapeutics Inc
Invest in Sage Therapeutics Inc
Today
Create an eToro account to buy SAGE stock on a secure, user-friendly, multi-asset trading platform.
Buy SAGE

FAQ

The current price of SAGE is 5.48.
The average price target for Sage Therapeutics Inc is 5.48. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Sage Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Sage Therapeutics Inc is 335.23M
Daily Movers
Explore the biggest stocks movers on the market.
Buy SAGE
Scroll to top